Paloma Partners’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-35,178
Closed -$545K 1628
2022
Q1
$545K Buy
+35,178
New +$444K 0.02% 711
2021
Q2
Sell
-26,301
Closed -$188K 2179
2021
Q1
$188K Buy
+26,301
New +$185K ﹤0.01% 1797
2020
Q4
Sell
-50,104
Closed -$143K 2112
2020
Q3
$143K Buy
+50,104
New +$184K ﹤0.01% 1849
2020
Q1
Sell
-105,703
Closed -$1.11M 1909
2019
Q4
$1.11M Buy
105,703
+24,760
+31% +$224K 0.02% 896
2019
Q3
$692K Buy
80,943
+4,901
+6% +$48.1K 0.01% 940
2019
Q2
$875K Buy
+76,042
New +$979K 0.01% 760
2019
Q1
Sell
-17,870
Closed -$185K 1880
2018
Q4
$185K Buy
17,870
+2,661
+17% +$39.2K 0.01% 1069
2018
Q3
$261K Sell
15,209
-11,084
-42% -$190K ﹤0.01% 1284
2018
Q2
$472K Buy
26,293
+9,198
+54% +$184K 0.01% 1058
2018
Q1
$300K Sell
17,095
-33,782
-66% -$705K ﹤0.01% 1624
2017
Q4
$1.17M Sell
50,877
-28,199
-36% -$584K 0.02% 962
2017
Q3
$1.66M Buy
79,076
+43,928
+125% +$809K 0.02% 863
2017
Q2
$710K Sell
35,148
-836,314
-96% -$18.2M 0.01% 1365
2017
Q1
$21.2M Buy
871,462
+803,119
+1,175% +$21.7M 0.25% 57
2016
Q4
$1.84M Buy
68,343
+19,196
+39% +$474K 0.02% 729
2016
Q3
$1.1M Sell
49,147
-23,449
-32% -$471K 0.01% 949
2016
Q2
$1.55M Sell
72,596
-3,013
-4% -$56.8K 0.02% 871
2016
Q1
$1.33M Buy
75,609
+64,309
+569% +$959K 0.02% 702
2015
Q4
$171K Buy
+11,300
New +$174K ﹤0.01% 1571
2015
Q3
Sell
-82,199
Closed -$1.55M 1853
2015
Q2
$1.55M Buy
+82,199
New +$1.71M 0.03% 553
2014
Q1
Sell
-15,035
Closed -$380K 937
2013
Q4
$380K Buy
+15,035
New +$360K 0.02% 688

Other funds holding PTEN

Paloma Partners's PTEN Position: Q2 2022 in Review

Paloma Partners sold out of Patterson-UTI (PTEN) in Q2 2022, closing a stake of 35,178 shares — an estimated $545K sold.

Paloma Partners first reported a position in PTEN in Q4 2013 and held it in 21 quarters. The position peaked at $21.2M in Q1 2017. 268 funds tracked by Wall St. Rank hold PTEN as of Q2 2022.

  • Paloma Partners reported no remaining Patterson-UTI position as of Q2 2022 after selling out during the quarter.
  • Paloma Partners sold 35,178 Patterson-UTI shares in Q2 2022, an estimated $545K.
  • Paloma Partners first reported a position in Patterson-UTI in Q4 2013 and held it in 21 quarters.
  • Paloma Partners's Patterson-UTI position peaked at $21.2M in Q1 2017.
  • 268 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2022.

Based on Paloma Partners's 13F filing for Q2 2022, filed 15 Aug 2022.